ArticleOncology letters2018
JAK2/STAT3 pathway as a therapeutic target in ovarian cancers.
Tomoyuki Yoshikawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
40 papers cite it
this paperpooled itcites it
ArticleOncology letters2018
Tomoyuki Yoshikawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.